Infectious Disease

Coronavirus (COVID-19)/Influenza A/B (Flu A/B) Antigen Combo Rapid Test

Powered by NomoFlow™

15-Minute Results Detects COVID-19, Flu A, and Flu B Easy to Use

Rapidly detect and differentiate SARS-CoV-2, Influenza A, and Influenza B antigens from nasal or nasopharyngeal swab samples.

A Foundation of Trust

Powered by NomoFlow™
CE Certified
ISO 13485

Why Choose a Combo Test?

In the setting of overlapping symptoms, a combo test allows for the simultaneous detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B, enabling timely diagnosis and appropriate treatment decisions.

Inside NomoFlow™: The Source of This Test's Superior Performance

The Coronavirus (COVID-19)/Influenza A/B Antigen Combo Rapid Test demonstrates excellent performance in detecting SARS-CoV-2, Influenza A, and Influenza B antigens.

Clinical Performance Data

Analyte Sensitivity (PPA) Specificity (NPA) Overall Agreement
SARS-CoV-2 (COVID-19) Antigen 92.5% (95% CI: 85.7% - 96.4%) 99.0% (95% CI: 97.2% - 99.7%) 97.8%
Influenza A Antigen 91.2% (95% CI: 83.9% - 95.5%) 98.5% (95% CI: 96.5% - 99.4%) 96.5%
Influenza B Antigen 89.5% (95% CI: 81.7% - 94.3%) 99.2% (95% CI: 97.4% - 99.8%) 96.1%

Relevant studies and publications will be available here soon.

Time to Result 15 minutes
Sample Type Nasopharyngeal Swab, Nasal Swab
Kit Size 25 Tests/Kit
Storage Conditions 2-30u00b0C
Shelf Life 24 months
Included Materials Test cassettes, sterile swabs, extraction buffer, package insert
Required Materials (Not Included) Timer
Certifications CE, ISO 13485

1

Collect Sample

Collect a nasopharyngeal or nasal swab sample according to standard procedures.

2

Process Sample

Mix the swab with the extraction buffer.

3

Read Results

Read the results at 15 minutes. Do not interpret results after 20 minutes.

Product Information

  • Catalog Number: VIR-COVF50
  • Product Name: Coronavirus (COVID-19)/Influenza A/B Antigen Combo Rapid Test

Download the product insert and other relevant documents for the Coronavirus (COVID-19)/Influenza A/B Antigen Combo Rapid Test.

Support

Frequently Asked Questions

Direct answers regarding clinical performance, workflow, and logistics.

This test is used to detect the presence of SARS-CoV-2, Influenza A, and Influenza B antigens, indicating an active infection.
The test can be performed using nasopharyngeal or nasal swab samples.
Results are available in 15 minutes.

Have more specific technical or clinical questions?

Connect with a Clinical Application Specialist

For Clinical Professionals

Integrate into a Complete Respiratory Workflow

This test is a key component of a broader strategy for managing respiratory outbreaks, optimizing resource allocation, and improving patient outcomes. See how it fits into a complete workflow solution.

Explore Workflow Solutions

For Strategic Partners

Inject the Power of NomoFlow™ into Your Brand

Build your brand on our foundation of verifiable reliability. Our NomoFlow™ platform is available for OEM/ODM partnerships, offering superior products with complete manufacturing transparency.

Discover Partnership Value

Take the Next Step Towards Verifiable Reliability

Equip your facility with diagnostic tools engineered for certainty. Select your path below to get started.

Experience the Difference

Request evaluation samples for your laboratory validation.

Request Samples

Clinical Consultation

Discuss workflow integration with an application specialist.

Contact Support

Commercial Partnership

Inquire about distribution or OEM/ODM opportunities.

Become a Partner